A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus

NCT00660309 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Aliskiren
DRUG: Irbesartan
DRUG: Captopril

Sponsor

Novartis